vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Diversified Energy Co (DEC). Click either name above to swap in a different company.

Diversified Energy Co is the larger business by last-quarter revenue ($666.5M vs $487.7M, roughly 1.4× CLOVER HEALTH INVESTMENTS, CORP.). Diversified Energy Co runs the higher net margin — 29.3% vs -10.1%, a 39.4% gap on every dollar of revenue. Diversified Energy Co produced more free cash flow last quarter ($280.0M vs $-69.0M).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

DTE Energy is a Detroit-based diversified energy company involved in the development and management of energy-related businesses and services in the United States and Canada. Its operating units include an electric utility serving 2.2 million customers and a natural gas utility serving 1.3 million customers in Michigan.

CLOV vs DEC — Head-to-Head

Bigger by revenue
DEC
DEC
1.4× larger
DEC
$666.5M
$487.7M
CLOV
Higher net margin
DEC
DEC
39.4% more per $
DEC
29.3%
-10.1%
CLOV
More free cash flow
DEC
DEC
$349.0M more FCF
DEC
$280.0M
$-69.0M
CLOV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
DEC
DEC
Revenue
$487.7M
$666.5M
Net Profit
$-49.3M
$195.5M
Gross Margin
Operating Margin
-10.1%
37.6%
Net Margin
-10.1%
29.3%
Revenue YoY
44.7%
Net Profit YoY
-123.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
DEC
DEC
Q4 25
$487.7M
$666.5M
Q3 25
$496.6M
$499.8M
Q2 25
$477.6M
$600.3M
Q1 25
$462.3M
Q4 24
$337.0M
Q3 24
$331.0M
Q2 24
$356.3M
Q1 24
$346.9M
Net Profit
CLOV
CLOV
DEC
DEC
Q4 25
$-49.3M
$195.5M
Q3 25
$-24.4M
$171.1M
Q2 25
$-10.6M
$297.7M
Q1 25
$-1.3M
Q4 24
$-22.1M
Q3 24
$-9.2M
Q2 24
$7.4M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
DEC
DEC
Q4 25
Q3 25
Q2 25
44.7%
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
DEC
DEC
Q4 25
-10.1%
37.6%
Q3 25
-4.9%
36.2%
Q2 25
-2.2%
48.5%
Q1 25
-0.3%
Q4 24
-6.4%
Q3 24
-2.7%
Q2 24
2.0%
Q1 24
-6.5%
Net Margin
CLOV
CLOV
DEC
DEC
Q4 25
-10.1%
29.3%
Q3 25
-4.9%
34.2%
Q2 25
-2.2%
49.6%
Q1 25
-0.3%
Q4 24
-6.6%
Q3 24
-2.8%
Q2 24
2.1%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
DEC
DEC
Q4 25
Q3 25
$2.14
Q2 25
$3.67
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
DEC
DEC
Cash + ST InvestmentsLiquidity on hand
$78.3M
$29.7M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$308.7M
$984.1M
Total Assets
$541.0M
$6.2B
Debt / EquityLower = less leverage
2.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
DEC
DEC
Q4 25
$78.3M
$29.7M
Q3 25
Q2 25
$23.7M
Q1 25
Q4 24
$194.5M
Q3 24
$288.0M
Q2 24
$254.8M
Q1 24
$208.3M
Total Debt
CLOV
CLOV
DEC
DEC
Q4 25
$2.7B
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLOV
CLOV
DEC
DEC
Q4 25
$308.7M
$984.1M
Q3 25
$340.9M
Q2 25
$344.2M
$727.7M
Q1 25
$336.1M
Q4 24
$341.1M
Q3 24
$342.2M
Q2 24
$324.9M
Q1 24
$292.5M
Total Assets
CLOV
CLOV
DEC
DEC
Q4 25
$541.0M
$6.2B
Q3 25
$559.7M
Q2 25
$575.0M
$5.7B
Q1 25
$583.7M
Q4 24
$580.7M
Q3 24
$653.0M
Q2 24
$674.2M
Q1 24
$671.8M
Debt / Equity
CLOV
CLOV
DEC
DEC
Q4 25
2.76×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
DEC
DEC
Operating Cash FlowLast quarter
$-66.9M
$464.6M
Free Cash FlowOCF − Capex
$-69.0M
$280.0M
FCF MarginFCF / Revenue
-14.1%
42.0%
Capex IntensityCapex / Revenue
0.4%
27.7%
Cash ConversionOCF / Net Profit
2.38×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
DEC
DEC
Q4 25
$-66.9M
$464.6M
Q3 25
$12.1M
Q2 25
$5.4M
$264.1M
Q1 25
$-16.3M
Q4 24
$34.8M
Q3 24
$50.0M
Q2 24
$44.8M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
DEC
DEC
Q4 25
$-69.0M
$280.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
DEC
DEC
Q4 25
-14.1%
42.0%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
DEC
DEC
Q4 25
0.4%
27.7%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
DEC
DEC
Q4 25
2.38×
Q3 25
Q2 25
0.89×
Q1 25
Q4 24
Q3 24
Q2 24
6.04×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons